The industry magazine “Plattform Life Sciences” asked investors and financing advisors about the mood after the Corona year 2020 and, among others, asked SHS partner Manfred Ulmer-Weber about current financing trends and how life science investors like SHS see the world “after” COVID-19.

In a Podcast Caroline Sai of EIT Health and our Partner Andre Zimmermann are discussing in which ways the new MDR is heavily affecting the whole European Medtech area – from start-ups to established medium-sized companies. In addition, SHS is out-lining in which way medium-sized companies and investors can team-up not only to overcome the economical challenges of the MDR for Medtechs but to prosper.

Tübingen-based healthcare investor SHS has provided capital and expertise to Crystal Laser Systems GmbH (CryLaS) on its way to becoming a leading, profitable provider of laser technology and is handing over the baton to Silver Investment Partners SIP CryLaS enjoys an excellent reputation worldwide in the healthcare, biotech and semiconductor sectors with pulsed and CW […]

Digitization is one of the major challenges facing the medtech industry. Those who want to master them need courage, know-how and capital.

‘Brexit is done’, as British Prime Minister Johnson wholeheartedly announced. But what does this mean for the SME-based healthcare and medtech sector? Read about it the current column by Dr. André Zimmermann.

The Single Use Support GmbH (SUS) product system for use in the deep-frozen transport of sensitive substances is well on its way to becoming the gold standard in liquid logistics. Companies all over the world, in the fields of life science, biotech and pharma, including firms engaged in research for coronavirus vaccines, rely on products […]

The Dutch medtech company Salvia BioElectronics B.V. specialises in the treatment of chronic migraine with electromedical solutions for neurostimulation. The news that Salvia has received the coveted Breakthrough Device Designation from the United States FDA gives creates a reason for hope among millions of migraine patients in the USA. This will significantly accelerate the approval […]

‘Milestones in medical technology’ is the title of a new series of the SHS Newsletter. In future, you can regularly read about innovations from the world of medical technology that have had a profound influence on our lives. Today’s milestone concerns a tiny balloon that has already saved countless lives. We thank the University Library […]

Coming up with reliable figures for the process of infection with the coronavirus requires tests that are dependable and, above all, quick. With the Octea SARS-CoV-2 system, GNA Biosolutions has developed a molecular, highly sensitive test method that delivers a test result with 96.7 percent accuracy in decentralized laboratories in approximately 40 minutes’ time. Octea […]

Develco Pharma, a Swiss-German firm, has been developing and producing orally administered, delayed-release drugs with special formulations since 2006. Since 2016, the company has produced these drugs in a state-of-the-art production facility located in Schopfheim, in the Baden region of Germany. The dynamic, medium-sized company is gradually growing its pipeline for new drugs, and there […]

For the medium-sized Swiss firm Tri Dental Implants Int. AG, CE approval for matrix®, the world’s first digital dental implant, represents a breakthrough! This is a real milestone for matrix®, which permits realisation of single-tooth treatment or multi-unit bridges directly on the implant, without the use of an abutment. The CE approval means that the […]

In Germany alone, there are some 20 million individuals suffering from mental illness. Depressive disorders are very common. The online app by Selfapy, which takes the form of a course with interactive exercises, helps sufferers free themselves from negative mindsets and thus improve their mood. The Selfapy offer is scientifically sound and is supervised by […]